Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR Newswire —
LOS ANGELES, March 2, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: INO). IF YOU SUFFERED A LOSS ON...